11 results
6-K
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
that it had determined, in light of the current macroeconomic climate and challenging funding environment, to commence its Global Phase 3 program
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
and asthma,” said Zheng Wei, PhD, Co-Founder and CEO of Connect Biopharma. “Yet, in light of the current macroeconomic climate and challenging funding
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
and potentially adverse tax consequences;
changes in a specific country’s or region’s political and cultural climate or economic condition;
economic weakness
F-1/A
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
;
changes in a specific country’s or region’s political and cultural climate or economic condition;
economic weakness, including inflation
F-1
jv7dkm 1z
26 Feb 21
Registration statement (foreign)
4:56pm
20-F
c2a0oqv7v ge
31 Mar 22
Annual report (foreign)
4:33pm
DRS/A
nsu184
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
q75nq0zziicsoh1h
17 Dec 20
Draft registration statement
12:00am
F-1/A
7k0mj7 dqb
18 Mar 21
Registration statement (foreign) (amended)
6:15am
- Prev
- 1
- Next